NLRP3 and pulmonary fibrosis: Similarly, pharmacological suppression of PFKFB3 elicits anti-inflammatory and antifibrotic effects in experimental pulmonary fibrosis, concurrently diminishing NLRP3 activation (Liu C, et al., 2024).